BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 12388190)

  • 1. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
    Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein is fully active after multiple tryptophan substitutions.
    Swartz DJ; Weber J; Urbatsch IL
    Biochim Biophys Acta; 2013 Mar; 1828(3):1159-68. PubMed ID: 23261390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
    Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
    Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3.
    Zhang DW; Gu HM; Vasa M; Muredda M; Cole SP; Deeley RG
    Biochemistry; 2003 Aug; 42(33):9989-10000. PubMed ID: 12924948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of a highly conserved proline residue in MRP1, MRP2, and MRP3 reveals a partially conserved function.
    Létourneau IJ; Slot AJ; Deeley RG; Cole SP
    Drug Metab Dispos; 2007 Aug; 35(8):1372-9. PubMed ID: 17494643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of amphipathic anions by human multidrug resistance protein 3.
    Zeng H; Liu G; Rea PA; Kruh GD
    Cancer Res; 2000 Sep; 60(17):4779-84. PubMed ID: 10987286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity.
    Ito K; Oleschuk CJ; Westlake C; Vasa MZ; Deeley RG; Cole SP
    J Biol Chem; 2001 Oct; 276(41):38108-14. PubMed ID: 11500505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
    Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
    Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3.
    Oleschuk CJ; Deeley RG; Cole SP
    Am J Physiol Gastrointest Liver Physiol; 2003 Feb; 284(2):G280-9. PubMed ID: 12388190
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.